Compare KNSA & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNSA | TPC |
|---|---|---|
| Founded | 2015 | 1894 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | General Bldg Contractors - Nonresidential Bldgs |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2018 | N/A |
| Metric | KNSA | TPC |
|---|---|---|
| Price | $41.52 | $67.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $51.33 | ★ $82.00 |
| AVG Volume (30 Days) | 345.4K | ★ 496.1K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | $597,973,000.00 | ★ $5,103,323,000.00 |
| Revenue This Year | $62.63 | $25.77 |
| Revenue Next Year | $29.93 | $14.81 |
| P/E Ratio | $89.09 | ★ N/A |
| Revenue Growth | ★ 55.68 | 19.22 |
| 52 Week Low | $17.82 | $18.34 |
| 52 Week High | $42.98 | $77.00 |
| Indicator | KNSA | TPC |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 54.62 |
| Support Level | $40.33 | $65.58 |
| Resistance Level | $42.32 | $70.77 |
| Average True Range (ATR) | 1.45 | 2.40 |
| MACD | -0.13 | 0.21 |
| Stochastic Oscillator | 56.68 | 62.61 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.